“We need to be talking much more about the whole constellation of possibilities around human stem cell IVF,” writes Paul Knoepfler.

The magnitude of disruption accompanying AI and data democratization is something most doctors still can’t see.

“This isn't scientific disagreement. It's either staggering incompetence or willful misrepresentation,” writes infectious disease physician Jake Scott...

AHRQ has been gutted by staff cuts that leave it unable to fund research designed to improve care.

The AMA has shifted from a behind-the-scenes lobbying strategy to more forceful public advocacy against President Trump's health care policies.

The inclusion of pregnant participants in RCTs has remained flat over the past 15 years. Changing this norm will require institutional-level reforms.

“If we don’t act now, we’ll lose one of the most efficient, cost-effective access points in the U.S. health care system,” writes Walgreens’ chief phar...

Insecure about their looks, more men than ever are getting plastic surgery.

Pfizer said its antibody-drug conjugate Padcev extended survival when combined with the immunotherapy Keytruda in some patients with invasive bladder...

Ambient scribe company Abridge, partnering with Highmark Health, says it can give information on prior authorization during, not just after, a patient...